KVUE
Kenvue Inc.
NYSE · Consumer Defensive · Household & Personal Products · US
$17.91
+0.73%Price chart
Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9Sep 14
ValuationView details →
P/E (Fwd)
14.9x
EV/EBITDA
13.2x
Market Cap
$34.40B
MomentumView details →
1D Return
+0.73%
YTD Return
+4.90%
RSI (14)
38.8
ValuationView details →
P/E (Fwd)
14.9x
EV/EBITDA
13.2x
Market Cap
$34.40B
RSI (14)
38.8
MomentumView details →
1D Return
+0.73%
YTD Return
+4.90%
SummaryUpdated Jun 1, 2026
Kenvue Inc. (NYSE:KVUE) is a consumer health company that emerged as an independent entity in May 2023 following its spin-off from Johnson & Johnson. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue operates as one of the world's largest pure-play consumer health companies, managing a portfolio of trusted household brands that have been part of families' daily routines for decades. The company went public through an initial public offering in May 2023, marking its transition from being a subsidiary of J&J to a standalone publicly traded corporation focused exclusively on consumer health products.
Similar companies
Latest newsMore news →
Kimberly-Clark is preparing concessions to secure EU antitrust approval for its acquisition of Kenvue.8h agoKimberly-Clark is weighing asset sales as the European Union reviews its $40 billion acquisition of Kenvue.12h agoKimberly-Clark is preparing concessions to address EU antitrust concerns over its $40 billion bid for Kenvue, the maker of Tylenol, to help win approval after a preliminary review.13h ago